| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/05/2012 | US20120003315 Flowable Carrier Matrix |
| 01/05/2012 | US20120003300 Composition Comprising Vascular Endothelial Growth Factor (VEGF) for the Treatment of Hair Loss |
| 01/05/2012 | US20120003299 Novel hsp90-targeted anti-cancer chimeric peptide |
| 01/05/2012 | US20120003296 New methods of treating dry eye syndrome |
| 01/05/2012 | US20120003291 Nanobead releasing medical devices |
| 01/05/2012 | US20120003290 Method for reducing pain |
| 01/05/2012 | US20120003285 Method for manufacturing capsule series, and related capsule series |
| 01/05/2012 | US20120003283 Injectable Biomaterials |
| 01/05/2012 | US20120003280 Ceramic/structural protein composites and method of preparation thereof |
| 01/05/2012 | US20120003272 Concrete scaffold containing bmp-2 and made of bone powder and fibrin glue |
| 01/05/2012 | US20120003267 Therapeutic Agents |
| 01/05/2012 | US20120003259 Molecule |
| 01/05/2012 | US20120003248 Monomethylvaline compounds capable of conjugation to ligands |
| 01/05/2012 | US20120003247 Monomethylvaline compounds capable of conjugation to ligands |
| 01/05/2012 | US20120003246 Novel composition and methods for the treatment of psoriasis |
| 01/05/2012 | US20120003244 Methods for apcdd1 mediated regulation of hair growth and pigmentation and mutants thereof |
| 01/05/2012 | US20120003243 Yeast ectopically expressing abnormally processed proteins and uses therefor |
| 01/05/2012 | US20120003242 Modulating pdx-1 with pcif1, methods and uses thereof |
| 01/05/2012 | US20120003233 Human diacylglycerol acyltransferase 2 (dgat2) family members and uses therefor |
| 01/05/2012 | US20120003231 Cell surface molecule mediating cell adhesion and signal transmission |
| 01/05/2012 | US20120003230 Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier |
| 01/05/2012 | US20120003229 Modulators of cytokine mediated signalling pathways and integrin alphavbeta3 receptor antagonists for combination therapy |
| 01/05/2012 | US20120003227 Methods and compositions for the treatment and diagnosis of vascular inflammatory disorders or endothelial cell disorders |
| 01/05/2012 | US20120003222 Fzd8 extracellular domains and fzd8 extracellular domain fusion molecules and treatments using same |
| 01/05/2012 | US20120003219 Compositions and Methods to Treat Bone Related Disorders |
| 01/05/2012 | US20120003218 Antagonists of actriib and uses for increasing red blood cell levels |
| 01/05/2012 | US20120003216 Fgf21 mutants and uses thereof |
| 01/05/2012 | US20120003214 Binding Moieties Based On Shark IgNAR Domains |
| 01/05/2012 | US20120003207 Methods and compositions for modulating proline levels |
| 01/05/2012 | US20120003206 Liquid, aqueous pharmaceutical compositions of factor vii polypeptides |
| 01/05/2012 | US20120003205 Pharmaceutical composition containing arazyme for the prevention of liver dysfunction |
| 01/05/2012 | US20120003204 Composition containing arazyme for the prevention and treatment of cander |
| 01/05/2012 | US20120003203 Compositions and Methods for Treating S. Pneumoniae Infection |
| 01/05/2012 | US20120003202 Cns delivery of therapeutic agents |
| 01/05/2012 | US20120003201 Vault agents for chronic kidney disease |
| 01/05/2012 | US20120003200 Biologically active food supplement |
| 01/05/2012 | US20120003191 Valproic acid, derivatives, analogues, and compositions including same and methods for their therapeutic use |
| 01/05/2012 | US20120003188 Compositions and Methods of Using Living and Non-Living Bioactive Devices with Components Derived from Self-Renewing Colony Forming Cells Cultured and Expanded In Vitro |
| 01/05/2012 | US20120003184 Sodium salt of 5-cyclopropyl-2-benzoic acid as dhodh inhibitor |
| 01/05/2012 | US20120003183 Addition salts of tromethamine with azabiphenylaminobenzoic acid derivatives as dhodh inhibitors |
| 01/05/2012 | US20120003182 Genetic severity markers in multiple sclerosis |
| 01/05/2012 | US20120003181 Novel Retinoid Inducible Factor and Uses Thereof |
| 01/05/2012 | US20120003180 Perlecan domain v protects, repairs and restores ischemic brain stroke injury and motor function |
| 01/05/2012 | US20120003179 Anti-ctla-4 and cpg-motif-containing synthetic oligodeoxynucleotide combination therapy for cancer treatment |
| 01/05/2012 | US20120003178 Evaluating the therapeutic potential of a glucan |
| 01/05/2012 | US20120003177 Curcumin-containing polymers and water-soluble curcumin derivatives as prodrugs of prodrug carriers |
| 01/05/2012 | US20120003119 Antimicrobial peptides |
| 01/05/2012 | DE102010025972A1 Determining protease in biological sample, comprises converting proform of protease into active protease, contacting test sample with substrate, at which inhibitor binding substance is bound and separating substrate with protease inhibitor |
| 01/05/2012 | DE102010025970A1 Verfahren zur Bestimmung von Proteasen und ihren Proformen A method for the determination of proteases and their pro-forms |
| 01/05/2012 | DE102010025935A1 Collagen with specified proline to hydroxyproline ratio and glycosylation degree as measured by the ratio of disaccharides to monosaccharides, useful as wound gel for treating wounds, and for tissue engineering |
| 01/05/2012 | CA2840546A1 A method for preparing a bone protein preparation and a bone protein preparation |
| 01/05/2012 | CA2805024A1 Polypeptides and uses thereof as a drug for treatment of multiples sclerosis, rheumatoid arthritis and other autoimmune disorders |
| 01/05/2012 | CA2804760A1 Single-walled carbon nanotube/sirna complexes and methods related thereto |
| 01/05/2012 | CA2804413A1 Keloid treatment |
| 01/05/2012 | CA2804156A1 Preservative-free follicle stimulating hormone solution delivery device |
| 01/05/2012 | CA2804154A1 Perlecan domain v protects, repairs and restores ischemic brain stroke injury and motor function |
| 01/05/2012 | CA2803983A1 Functional vascularization with biocompatible polysaccharide-based hydrogels |
| 01/05/2012 | CA2803932A1 Lactoferrin sequences, compositions and methods of corneal wound treatment |
| 01/05/2012 | CA2803646A1 Short and d-amino acid-containing polypeptides for therapeutic conjugates and uses thereof |
| 01/05/2012 | CA2801010A1 Novel peptide and use thereof |
| 01/05/2012 | CA2793502A1 Desmopressin for reducing nocturnal voids |
| 01/04/2012 | EP2402444A1 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| 01/04/2012 | EP2402435A2 Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy |
| 01/04/2012 | EP2402366A1 Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, und use thereof |
| 01/04/2012 | EP2402364A2 A nonapeptide with anti-tumour activity |
| 01/04/2012 | EP2402034A1 A method for screening for a substance having an action of proliferating natural killer cells |
| 01/04/2012 | EP2402026A2 Method for isolating hepatitis C virus peptides |
| 01/04/2012 | EP2402009A1 Inhibitors of serine protease, particularly hepatitis c virus NS3-NS4A protease, incorporating a fused ring system |
| 01/04/2012 | EP2401301A2 Apparatus, system, and method for creating immunologically enhanced spaces in-vivo |
| 01/04/2012 | EP2401300A1 ANTI-C mX ANTIBODIES CAPABLE OF BINDING TO HUMAN mIgE ON B LYMPHOCYTES |
| 01/04/2012 | EP2401293A2 Designer ligands of tgf-beta superfamily |
| 01/04/2012 | EP2400988A1 Compositions, use and method for the use of surface active proteins in topical drug delivery across keratin |
| 01/04/2012 | EP2400985A2 Combination of an either an anti-igf-1r antibody or an igf binding protein and a small molecule igf-1r kinase inhibitor |
| 01/04/2012 | EP2400980A2 Visfatin therapeutic agents for the treatment of acne and other conditions |
| 01/04/2012 | EP2400979A2 Compositions and methods for visualizing and eliminating cancer stem cells |
| 01/04/2012 | EP2400978A2 Analogues of neuropeptide y having proline substitution at position 34 |
| 01/04/2012 | EP2400977A1 Peptidomimetic cyclic compounds for treating retinitis pigmentosa |
| 01/04/2012 | EP2400976A1 Soft protease inhibitors, and pro-soft forms thereof |
| 01/04/2012 | EP2400975A1 Use of guanylyl cyclase c agonists to suppress appetite |
| 01/04/2012 | EP2400974A2 Synthetic diblock copolypeptide hydrogels for use in the central nervous system |
| 01/04/2012 | EP2400973A2 Identification of extracellular form of pten that can be used to treat tumors |
| 01/04/2012 | EP2400883A1 Drug delivery management systems and methods |
| 01/04/2012 | EP2182923B1 Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof |
| 01/04/2012 | EP2175877B1 Use of mutated antithrombins for treating or preventing coagulation disorders |
| 01/04/2012 | EP2059587B1 Laccases for pulp bio-bleaching |
| 01/04/2012 | EP2047857B1 Agent for injection purposes comprising antibiotic, and solution for injection comprising the agent |
| 01/04/2012 | EP2046822B1 Molecular probe for sphingolipids |
| 01/04/2012 | EP2004352B1 Amino acid surrogates for peptidic constructs |
| 01/04/2012 | EP1948217B1 Use of nerve growth factor in eye-drops for therapy of pathologies of the central nervous system, such as alzheimer's and parkinson's disease |
| 01/04/2012 | EP1863832B1 Age inhibitors |
| 01/04/2012 | EP1624847B1 Compositions and methods for the preparation of human growth hormone glycosylation mutants |
| 01/04/2012 | EP1620058B1 Composition for improving cognition and memory |
| 01/04/2012 | EP1441720B1 Inhibitors of serine protease, particularly hepatitis c virus ns3-ns4a protease, incorporating a fused ring system |
| 01/04/2012 | EP1187850B1 Antimicrobial theta defensins and methods of using same |
| 01/04/2012 | EP1080107B1 Novel peptides which represent the epitopes of the human herpes virus type 8 |
| 01/04/2012 | EP0914142B9 Peptides with increased binding affinity for at least three hla-a3-like molecules |
| 01/04/2012 | CN1944460B Alr polypeptide and application thereof |
| 01/04/2012 | CN1896108B Preparation of specific anticoagulation matter and its use |
| 01/04/2012 | CN1798838B Inhibitor proteins of a protease and use thereof |
| 01/04/2012 | CN1740195B Polypeptide gapM1 and its prepn process |